A Histone Deacetylase Activity Model for the Discovery and Validation of Sepsis Biomarkers
Puntos clave
The research aims to identify biomarkers related to histone deacetylase activity for sepsis.
Utilized a model focusing on histone deacetylase activity
Identified specific biomarkers associated with sepsis
Validated findings through relevant biochemical analyses
TOM1L2 and TRIM24 were identified as significant biomarkers for sepsis
These biomarkers provide potential avenues for early diagnosis
Findings suggest new targets for sepsis treatment strategies
Resumen
This study identified TOM1L2 and TRIM24 as key HDAC-related biomarkers for sepsis, providing novel insights for the early diagnosis and targeted treatments of sepsis.